We are live on
!
Find out more
Walleye Capital Portfolio holdings
AUM
$24B
1-Year Est. Return
37.67%
This Fund
S&P 500
This Quarter
Est. Return
-4.15%
1 Year Est. Return
+37.67%
3 Year Est. Return
+98.01%
5 Year Est. Return
+160%
10 Year Est. Return
–
AUM
$1.68B
AUM Growth
+$769M
(+84%)
Cap. Flow
+$831M
Cap. Flow
% of AUM
49.48%
Top 10 Holdings %
Top 10 Hldgs %
8.16%
Holding
2,474
New
799
Increased
624
Reduced
373
Closed
629
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.65M |
| 2 |
NFINU
Netfin Acquisition Corp. Unit
NFINU
|
+$2.57M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$2.42M |
| 4 |
Humana
HUM
|
+$2.37M |
| 5 |
Cigna
CI
|
+$2.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JFKKU
8i Enterprises Acquisition Corp Unit
JFKKU
|
+$1.58M |
| 2 |
GIX.U
GigCapital2, Inc.
GIX.U
|
+$1.35M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$1.31M |
| 4 |
CHAC.U
Chardan Healthcare Acquisition Corp.
CHAC.U
|
+$1.27M |
| 5 |
Artisan Partners
APAM
|
+$1.24M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.91% |
| 2 | Technology | 1.1% |
| 3 | Consumer Discretionary | 1.05% |
| 4 | Communication Services | 0.58% |
| 5 | Materials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
CALL
AT&T
T
$169B
| $163K | 0.01% |
5,693
-102,213
| -95% | -$2.71M |
|
|
DPLO
1277
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $163K | 0.01% |
33,200
+1,200
| +4% | +$6.71K |
|
|
EMF
1278
Templeton Emerging Markets Fund
EMF
$305M
| $162K | 0.01% |
+11,050
| New | +$163K |
|
1279
OSI Systems
OSIS
$3.64B
| $161K | 0.01% |
1,582
+1,082
| +216% | +$117K |
|
|
WORK
1280
DELISTED
Slack Technologies, Inc.
WORK
| $161K | 0.01% |
+6,754
| New | +$205K |
|
1281
CALL
Intuit
INTU
$85.6B
| $160K | 0.01% |
600
-6,100
| -91% | -$1.68M |
|
1282
CALL
Interface
TILE
$2B
| $160K | 0.01% |
11,100
+1,100
| +11% | +$14.4K |
|
|
NVTA
1283
DELISTED
Invitae Corporation
NVTA
| $159K | 0.01% |
8,276
+7,457
| +911% | +$176K |
|
1284
Conduent
CNDT
$251M
| $158K | 0.01% |
+25,400
| New | +$196K |
|
|
HZNP
1285
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $158K | 0.01% |
5,800
+1,800
| +45% | +$46.5K |
|
1286
PUT
Electronic Arts
EA
$52.4B
| $157K | 0.01% |
+1,600
| New | +$150K |
|
|
RST
1287
DELISTED
ROSETTA STONE INC
RST
| $157K | 0.01% |
9,030
-19,159
| -68% | -$386K |
|
|
PCTI
1288
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $156K | 0.01% |
+18,571
| New | +$110K |
|
|
AAIC
1289
DELISTED
Arlington Asset Investment Corp.
AAIC
| $156K | 0.01% |
+28,400
| New | +$167K |
|
1290
CALL
Acadia Pharmaceuticals
ACAD
$4.45B
| $155K | 0.01% |
4,300
-32,100
| -88% | -$973K |
|
|
PRO
1291
CALL
DELISTED
PROS Holdings
PRO
| $155K | 0.01% |
2,600
+2,500
| +2,500% | +$168K |
|
1292
CALL
Patterson-UTI
PTEN
$3.48B
| $155K | 0.01% |
18,100
+3,100
| +21% | +$30.4K |
|
|
SABA
1293
Saba Capital Income & Opportunities Fund II
SABA
$221M
| $155K | 0.01% |
12,600
-4,500
| -26% | -$56.4K |
|
1294
PUT
Accenture
ACN
$101B
| $154K | 0.01% |
800
+600
| +300% | +$116K |
|
1295
Centene
CNC
$31.6B
| $154K | 0.01% |
+3,557
| New | +$173K |
|
1296
PUT
Darden Restaurants
DRI
$23.7B
| $154K | 0.01% |
1,300
-2,600
| -67% | -$317K |
|
|
HAPN
1297
CALL
Happen Inc
HAPN
$2.19B
| $154K | 0.01% |
+11,800
| New | +$170K |
|
1298
PUT
Intellia Therapeutics
NTLA
$1.52B
| $154K | 0.01% |
11,500
-2,000
| -15% | -$31.9K |
|
|
PPLI
1299
PUT
People Inc
PPLI
$3.13B
| $153K | 0.01% |
3,917
-6,714
| -63% | -$287K |
|
1300
PUT
Merck
MRK
$326B
| $152K | 0.01% |
1,886
-6,288
| -77% | -$504K |
|
Similar funds
JG
SC
OAG
CS
Walleye Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Walleye Capital held 2,474 positions worth $1.68B, up 84% from $910M the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.
Walleye Capital deployed $831M of net new capital in Q3 2019, opening 799 new positions and adding to 624 existing holdings. Its largest new stake was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, up from 1.8% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Arqule Inc, an estimated $1.22M trimmed.
- Walleye Capital's largest Q3 2019 buy was Meta Platforms (Facebook): 13,918 shares worth $2.48M.
- Walleye Capital added most to Abiomed Inc in Q3 2019, an estimated $2.42M increase.
- Walleye Capital's biggest Q3 2019 reduction was Arqule Inc, cutting an estimated $1.22M.
- Walleye Capital fully exited 8i Enterprises Acquisition Corp Unit in Q3 2019, selling an estimated $1.58M.
- Walleye Capital's ten largest holdings make up 8.2% of its $1.68B portfolio in Q3 2019.
- Walleye Capital opened 799 new positions and closed 629 in Q3 2019.
- Walleye Capital's portfolio value rose 84% quarter-over-quarter to $1.68B.
Based on Walleye Capital's 13F filing for Q3 2019, filed 14 Nov 2019.